Merry Medical Races to Hong Kong Again After Prospective Prospectus Expires

Merry Medical swiftly updated its information to the Hong Kong Stock Exchange a day after the expiration of its initial prospectus filed six months ago on May 10, 2026. The company, with Huatai International and JPMorgan as joint sponsors, displayed its determination to pursue a dual listing on the “A+H” platform by presenting the latest financial data and operational details. Despite the challenges in the domestic medical device industry, Merry Medical’s overseas business revenue surpassed the domestic revenue for the first time in 2025, reaching 53%, with international operations becoming the main growth driver. As the company navigates through industry…